Skip to Primary Navigation

Strategic paths for pharma in a tariff-driven world

A pharmacist works at a pharmacy in Manhattan in New York City.
Photo: Spencer Platt/Getty Images

From short-term moves to long-term manufacturing bets, global reforms are still needed to stabilize the system.

When policy shifts arrive abruptly, the instinct may be to react defensively or wait out the turbulence. The recent wave of US tariffs has sent ripples through a sector already grappling with global dependencies and domestic constraints.

So what can companies do now to adapt swiftly, and what long-term investments

Get full access, free for a month

Start your 28-day free trial to continue reading and access
all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience